RIBECCA - A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole

Autor: Schmidt-Wetzel, S, Decker, T, Kuemmel, S, Lueftner, D, Fasching, PA, Schneeweiss, A, Brucker, S, Schuler, M, Janni, W, Guderian, G, Fehm, T, Schubert, J, Reiners, R
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Databáze: OpenAIRE